Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R MacGregor

Showing results (281-290 of 465) with videos related to

Pageof 47
Sort By:
British Medical Journal (Clinical Research Ed.)|February 9, 1985
Prescribing: the power to set limitsJ M Harding, M Modell, S Freudenberg, et al.
Basic & Clinical Pharmacology & Toxicology|October 28, 2010
Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective studyFenglei Huang, Paul Scholl, David B Huang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1992
Is [1-11C]putrescine useful as a brain tumor marker?E M Hiesiger, J S Fowler, J Logan, et al.
Biochemical and Biophysical Research Communications|July 30, 2005
Purification of normal cellular prion protein from human platelets and the formation of a high molecular weight prion protein complex following platelet activationMichael Jones, Mark W Head, John G Connolly, et al.
Biopharmaceutics & Drug Disposition|March 4, 2000
Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteersM J Lamson, J P Sabo, T R MacGregor, et al.
BMC Neurology|June 26, 2007
'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control studyRoss P Carne, Terence J O'Brien, Christine J Kilpatrick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
C1.7 antigen expression on CD8+ T cells is activation dependent: increased proportion of C1.7+CD8+ T cells in HIV-1-infected patients with progressing diseaseD Peritt, D A Sesok-Pizzini, R Schretzenmair, et al.
Vaccine|February 1, 1995
Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside AfricaA A Machado, M Bakpabua, D Salaun, et al.
Synapse (New York, N.Y.)|November 1, 1992
Comparative PET studies of the kinetics and distribution of cocaine and cocaethylene in baboon brainJ S Fowler, N D Volkow, R R MacGregor, et al.
European Journal of Clinical Pharmacology|January 1, 1994
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart diseaseR A Wright, A M Perrie, F Stenhouse, et al.
Pageof 47

Showing results (281-290 of 465) with videos related to

Sort By:
Pageof 47
British Medical Journal (Clinical Research Ed.)|February 9, 1985
Prescribing: the power to set limitsJ M Harding, M Modell, S Freudenberg, et al.
Basic & Clinical Pharmacology & Toxicology|October 28, 2010
Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective studyFenglei Huang, Paul Scholl, David B Huang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1992
Is [1-11C]putrescine useful as a brain tumor marker?E M Hiesiger, J S Fowler, J Logan, et al.
Biochemical and Biophysical Research Communications|July 30, 2005
Purification of normal cellular prion protein from human platelets and the formation of a high molecular weight prion protein complex following platelet activationMichael Jones, Mark W Head, John G Connolly, et al.
Biopharmaceutics & Drug Disposition|March 4, 2000
Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteersM J Lamson, J P Sabo, T R MacGregor, et al.
BMC Neurology|June 26, 2007
'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control studyRoss P Carne, Terence J O'Brien, Christine J Kilpatrick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
C1.7 antigen expression on CD8+ T cells is activation dependent: increased proportion of C1.7+CD8+ T cells in HIV-1-infected patients with progressing diseaseD Peritt, D A Sesok-Pizzini, R Schretzenmair, et al.
Vaccine|February 1, 1995
Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside AfricaA A Machado, M Bakpabua, D Salaun, et al.
Synapse (New York, N.Y.)|November 1, 1992
Comparative PET studies of the kinetics and distribution of cocaine and cocaethylene in baboon brainJ S Fowler, N D Volkow, R R MacGregor, et al.
European Journal of Clinical Pharmacology|January 1, 1994
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart diseaseR A Wright, A M Perrie, F Stenhouse, et al.
Pageof 47